9_y_PoFP0cI https://histock.tw/talk/live.aspx?name=gtalk&id=1314 20250226 阿布波

台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    45.60
  • 漲跌
    ▼0.25
  • 漲幅
    -0.55%
  • 成交量
    88
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
生華科 (6492)籌碼相關-永豐金-竹北 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-竹北 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/24046.0000.0045.8501560.00%
2025/02/17045.1000.0044.7501620.00%
2025/01/2200.00142.3042.30-1228-0.44%
2024/12/27145.5500.0044.2514210.24%
2024/12/19142.4000.0042.5014840.21%
2024/11/20145.50145.3545.1006820.00%
2024/10/30151.0000.0050.5017770.13%
2024/10/28157.20256.5552.60-1756-0.13%
2024/10/04152.4000.0052.4011,0520.10%
2024/09/25054.0000.0053.8001,0180.00%
2024/09/24055.5000.0053.4001,0190.00%
2024/09/23054.4000.0054.6001,0190.00%
2024/09/13248.3800.0047.8029670.21%
2024/09/09547.7100.0048.2051,0340.48%
2024/08/2900.00551.1250.00-5993-0.50%
2024/08/14547.5500.0047.0559010.55%
2024/08/09249.205.449.1648.15-3.4879-0.39%
2024/08/0800.000.149.1649.75-0.1865-0.01%
2024/08/0700.000.351.0350.70-0.3856-0.03%
2024/08/06748.9600.0049.0078410.83%
2024/08/0200.00154.8053.00-1809-0.12%
2024/07/26055.70153.9854.50-1776-0.13%
2024/07/19860.58558.7058.1037350.41%
2024/07/18363.33163.1062.2026580.30%
2024/07/174.857.5300.0058.904.85430.88%
2024/07/16156.40157.2057.2004270.00%
2024/07/12347.000.147.3047.302.93280.88%
2024/06/26348.95348.9548.7502880.00%
2024/06/17344.80345.3045.3501870.00%
2024/06/0500.00242.5042.75-2151-1.32%
2024/06/04242.1000.0041.8021531.30%
2024/05/2200.00043.5043.250174-0.01%
2024/05/210.142.2000.0042.550.11730.06%
2024/05/2000.00042.2041.9501740.00%
2024/05/140.141.4900.0041.600.11790.06%
2024/05/0300.00042.9541.7501820.00%
2024/04/18042.5000.0041.9001820.00%
2024/04/17042.4500.0041.7501830.00%
2024/04/15042.7500.0042.3001870.00%
2024/03/13042.6000.0042.6002090.00%
2024/03/06044.0000.0043.4003310.00%
2024/03/04044.1000.0043.6003390.00%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音